Abstract
Background: Understanding the spectrum of SARS-CoV-2 infection and COVID-19 disease in people with HIV (PWH) is critical to provide clinical guidance and implement risk-reduction strategies. Objective: To characterize COVID-19 in PWH in the United States and identify predictors of disease severity. Design: Observational cohort study. Setting: Geographically diverse clinical sites in the CFAR Network of Integrated Clinical Systems (CNICS) Participants: Adults receiving HIV care through December 31, 2020. Measurements: COVID-19 cases and severity (hospitalization, intensive care, death). Results: Of 16,056 PWH in care, 649 were diagnosed with COVID-19 between March-December 2020. Case fatality was 2%; 106 (16.3%) were hospitalized and 12 died. PWH with current CD4 count 3 (aRR 2.68; 95%CI 1.93-3.71; P<.001) or lowest recorded CD4 count 3 , low CD4/CD8 ratio, and history of CD4 <200, have a clear excess risk of severe COVID-19, after accounting for comorbidities also associated with severe outcomes. PWH with these risk factors should be prioritized for COVID-19 vaccination, early treatment, and monitored closely for worsening illness.

This publication has 52 references indexed in Scilit: